Find policies, billing codes, payers, states, and providers
Gender Dysphoria Treatment
Customize your policy alerts
Sign up for Colorado Rocky Mountain Health Plans Policy CS145.T alerts
Get alerted when Policy CS145.T changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity criteria, covered and not medically necessary gender-affirming surgical procedures and associated therapies for members covered by Colorado Rocky Mountain Health Plans; excludes states listed under Application where this policy does not apply.
No material clinical or coverage changes in this revision.
Coverage Criteria and Medical Necessity
General surgical treatment criteria
Covered when ALL of the following are met:
Breast surgery specific criteria
For breast surgery a written clinical assessment is required and additional condition for augmentation:
Voice surgery specific criteria
For thyroid cartilage reduction/voice modification:
Voice therapy/lessons should be documented prior to phonosurgical interventions when applicable.
Genital surgery specific criteria
For genital surgery a higher level of assessment and preparatory requirements are mandated:
Document exceptions when hormone therapy is contraindicated or not desired; multidisciplinary agreement (MHP and endocrine clinician) is recommended prior to genital GAS.
Covered procedures list
When criteria are met, the following are considered medically necessary and covered:
List is non-exhaustive as detailed in policy; ancillary cosmetic procedures may be excluded as noted elsewhere.
Coverage Rationale (general statement)
Covered when plan and legal requirements are met
Refer to member-specific benefit language and governing federal/state requirements.
New York fully-insured plans
Special rule for NY fully-insured plans
Clinical review for ancillary cosmetic procedures is conducted case-by-case per NY requirements.
Endocrine Society — Surgery timing and prerequisites
Recommendations to consider before genital gender-affirming surgery:
Recommendations are drawn from Endocrine Society guidance and are based on low to very low quality evidence in places.
Adolescent phased care and criteria
Guidance for children and adolescents with gender dysphoria:
Multiple guidelines emphasize limited evidence, lack of consensus, and that some guidelines recommend waiting until age 16+ for hormones and age 18 for most surgeries.
Endocrine Society recommendations
Endocrine Society recommendations relevant to surgical timing and prerequisites
Recommendations are largely based on low to very low quality evidence and include good practice statements.
Examples of ancillary procedures the policy enumerates as cosmetic when performed as part of gender-affirming surgical treatment include: abdominoplasty (including panniculectomy-related procedures), blepharoplasty, body contouring (e.g., liposuction, fat transfer when done solely for contour), brow lift, calf, cheek, chin, nose, clavicular, or pectoral implants, injection of fillers or neurotoxins, face/forehead lift or neck tightening, facial bone remodeling, hair transplantation, lip augmentation or reduction, mastopexy, rhinoplasty, rib reconstruction, and skin resurfacing (e.g., dermabrasion, chemical peels, laser).
The policy also lists laser or electrolysis hair removal not related to genital reconstruction as an ancillary cosmetic procedure in the exclusions list.
The policy notes examples of services that are not covered, including treatment received outside of the United States and cosmetic procedures that do not meet the definition of a Covered Health Care Service under federal, state, or contractual requirements.
Providers and reviewers should check member-specific benefit language and governing requirements because coverage may vary and certain cosmetic ancillary procedures performed as part of surgical care are explicitly identified in the policy as not medically necessary.
Guideline reviews summarized in the policy emphasize a phased, multidisciplinary approach for children and adolescents: psychosocial support first, consideration of puberty suppression when indicated, then gender-affirming hormones, with most surgical interventions generally reserved for adulthood and considered case-by-case.
The evidence cited indicates there is limited and uncertain evidence
Informationally, the policy states that gender transformation surgeries themselves are procedures and therefore not subject to FDA regulation; however, medical devices, drugs, biologics, or tests used as part of these procedures may be regulated by the FDA.
The policy specifies that certain ancillary procedures listed in the coverage section are considered cosmetic and not medically necessary when performed as part of surgical treatment for Gender Dysphoria; examples include abdominoplasty, blepharoplasty, liposuction, implants, and skin resurfacing.
Review of coverage for these ancillary services should reference federal, state, or contractual benefit requirements because member plan language may affect whether any particular ancillary procedure is covered.
The policy notes that certain ancillary procedures may be treated as cosmetic and therefore not medically necessary when performed in conjunction with gender-affirming surgery; this includes, for example, procedures such as hair transplantation, lip augmentation/reduction, and facial cosmetic surgeries.
Because exclusions and limitations depend on plan language and governing requirements, individual determinations about ancillary procedures are made in the context of the member’s benefit contract and applicable federal/state rules.
The policy’s clinical evidence review characterizes the overall evidence base as limited by study quality, heterogeneity, and incomplete outcome reporting; as a result, it states that available evidence is often of low to very low quality for many surgical procedures.
Because outcomes and complication reporting are variable across studies, the policy concludes the magnitude of benefit and harm for individual surgical procedures cannot be estimated accurately, limiting precision in benefit–harm assessments and supporting the use of guideline-based clinical judgment for authorization decisions.
Applicable Procedure and Diagnosis Codes
| 11950 | Subcutaneous injection of filling material (e.g., collagen); 1 cc or less. |
| 11951 | Subcutaneous injection of filling material (e.g., collagen); 1.1 to 5.0 cc. |
| 11952 | Subcutaneous injection of filling material (e.g., collagen); 5.1 to 10.0 cc. |
| 11954 | Subcutaneous injection of filling material (e.g., collagen); over 10.0 cc. |
| 14000 | Adjacent tissue transfer or rearrangement, trunk; defect 10 sq cm or less. |
| 14001 | Adjacent tissue transfer or rearrangement, trunk; defect 10.1 sq cm to 30.0 sq cm. |
| 14041 | Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10.1 sq cm to 30.0 sq cm. |
| 15734 | Muscle, myocutaneous, or fasciocutaneous flap; trunk. |
| 15738 | Muscle, myocutaneous, or fasciocutaneous flap; lower extremity. |
| 15750 | Flap; neurovascular pedicle. |
| 54400 | Insertion of penile prosthesis; non-inflatable (semi-rigid). |
| 54401 | Insertion of penile prosthesis; inflatable (self-contained). |
| 54405 | Insertion of multi-component, inflatable penile prosthesis, including placement of pump, cylinders, and reservoir. |
| 54406 | Removal of all components of a multi-component, inflatable penile prosthesis without replacement of prosthesis. |
| 54408 | Repair of component(s) of a multi-component, inflatable penile prosthesis; removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis at the same operative session. |
| 54410 | Removal and replacement of all component(s) of a multi-component, inflatable penile prosthesis at the same operative session. |
| 54411 | Removal and replacement of all components of a multi-component inflatable penile prosthesis through an infected field at the same operative session, including irrigation and debridement of infected tissue. |
| 54416 | Removal of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis, without replacement. |
| 54417 | Removal and replacement of non-inflatable (semi-rigid) or inflatable (self-contained) penile prosthesis at the same operative session. |
| 54660 | Orchiectomy, simple (including subcapsular), with or without testicular prosthesis, scrotal or inguinal approach. |
| F64.0 | Transsexualism. |
| F64.1 | Dual role transvestism. |
| F64.2 | Gender identity disorder of childhood. |
| F64.8 | Other gender identity disorders. |
| F64.9 | Gender identity disorder, unspecified. |
| Z87.890 | Personal history of sex reassignment. |
Provider Steps, Prior Authorization, and Documentation
Prior authorization/clinical review required
Obtain prior authorization or clinical review documentation before proceeding with gender-affirming surgeries or related therapies; medical records and written clinical assessments documenting that the member meets all applicable clinical criteria are required for review and imply prior authorization/clinical review.
- Medical records documentation may be required to assess whether the member meets clinical criteria for coverage.
- Written clinical assessments are required for breast, voice, and genital procedures as specified in the Coverage Criteria.
Prior authorization may be required for listed surgical CPT codes
Obtain prior authorization per plan rules for procedures listed in the Applicable Codes section; many surgical CPT codes enumerated in the policy are subject to plan coverage determinations and require authorization prior to scheduling.
- Listing of a code in the policy does not guarantee coverage — verify plan-specific prior authorization requirements.
- Examples include CPT codes for penile prosthesis (54400–54417), orchiectomy (54660, 54690), vaginoplasty (57335), hysterectomy codes (58150–58573), and voice/therapy codes (92507, 92508).
Document age and multidisciplinary agreement for genital surgery
For genital gender-affirming surgery, document that patient meets guideline-based age and multidisciplinary prerequisites: surgery should generally be deferred until at least age 18 (or legal age of majority) and supported by agreement from a mental health practitioner and the clinician responsible for endocrine therapy.
- Endocrine Society suggests delaying genital surgery until ≥18 and requiring MHP and endocrine clinician agreement that surgery is medically necessary.
- Document completion of required multidisciplinary assessments in the medical record for authorization decisions.
Verify benefits and prior authorization processes
Verify the member’s benefit plan, applicable federal/state/contractual requirements, and the plan’s prior authorization processes before applying this policy; the terms of federal, state, or contractual requirements govern in case of conflict.
- Check plan-specific benefit language — not all plans cover every listed surgical treatment.
- In the event of conflict, federal/state/contractual requirements override this policy.
Document required preoperative therapy and real-life experience
Document required periods of prior therapy or real-life experience before surgery where specified: e.g., 12 months continuous hormone therapy for breast augmentation and genital surgery, and 12 months of full-time real-life experience for genital procedures when required by coverage criteria.
- Breast augmentation: continued Gender Dysphoria after completion of 12 months continuous hormone therapy is required.
- Genital surgery: complete at least 12 months continuous full‑time real-life involvement in the identified gender and 12 months continuous hormone therapy unless contraindicated.
Document voice therapy and hormone therapy before phonosurgery
Document completion of voice therapy lessons and recommend hormone therapy duration prior to voice procedures; voice modification surgery requires documentation of presurgical voice lessons/therapy, and reviews recommend at least 6 months of hormone therapy prior to masculinizing voice interventions.
- For voice modification surgery, include documentation of presurgical voice lessons and/or therapy.
- Hayes and others note hormone therapy is recommended for at least six months prior to further voice intervention.
Follow and document phased care approach in adolescents
For adolescents, follow a phased multidisciplinary care approach and document each stage: psychosocial support, consideration of puberty suppression when indicated, then hormones, with most surgical interventions deferred until adulthood unless plan-specific rules or exceptions apply.
- Most guidelines recommend psychosocial support → puberty suppression (as appropriate) → hormones → surgery in adulthood.
- Document capacity to consent, parental consent where applicable, and multidisciplinary team assessments for adolescents.
Document ≥1 year hormone therapy (or documented exception) before genital surgery
Document hormone therapy duration before genital surgery per guideline recommendations: the Endocrine Society recommends completion of at least one year of consistent hormone therapy before genital surgery unless hormones are contraindicated or not desired—document any exceptions.
- Include clear documentation of one year of consistent and compliant hormone treatment or a documented medical contraindication or patient decision not to undergo hormones.
- Physician responsible for endocrine treatment should medically clear the patient and collaborate with the surgeon regarding perioperative hormone use.
Submit required clinical documentation with authorization requests
Provide required clinical documentation in the medical record for all requests: persistent, well‑documented Gender Dysphoria; capacity to consent; written clinical assessments from Qualified Healthcare Professional(s) as specified by procedure; and treatment plans including ongoing follow-up.
- Written clinical assessment from at least one Qualified Healthcare Professional is required for breast and voice procedures.
- Genital surgery requires written clinical assessments from at least two Qualified Healthcare Professionals who independently assessed the individual.
- Include treatment plan documenting ongoing follow-up and care by a Qualified Healthcare Professional experienced in treating Gender Dysphoria.
Document diagnosis and confirm benefit determination
Establish and document an accurate diagnosis of gender incongruence or gender dysphoria; benefit coverage for listed surgical treatments is determined by federal, state, or contractual plan requirements and the member’s documented diagnosis.
- Accurate diagnosis (e.g., DSM-5-TR criteria for Gender Dysphoria) should be recorded in the medical record.
- Confirm plan-specific coverage determinations reference federal, state, or contractual requirements.
Document multidisciplinary clinician agreement that surgery is medically necessary
Include documentation that both the mental health practitioner and the clinician responsible for endocrine transition therapy agree surgery is medically necessary when indicated by guidelines; record clinician agreement and clearance per Endocrine Society recommendations.
- Endocrine Society recommends MHP and endocrine clinician agreement that surgery is medically necessary and documentation that the physician responsible for endocrine treatment medically clears the patient.
- Document satisfaction with hormonal effects and satisfactory social role change where applicable prior to referral for genital surgery.
Document clinical clearance and guideline adherence for authorization
Document clinical clearance and adherence to guideline-based criteria (age, mental health assessment, hormone therapy prerequisites) for authorization; note that federal/state/contractual requirements supersede policy where applicable.
- Providers should document adherence to Endocrine Society recommendations about age, mental health assessment, and hormone therapy prerequisites.
- Verify and document any federal/state/contractual requirements that govern coverage.
Documentation-related denial risk if records are incomplete
Be aware that lack of required documentation may lead to denial; ensure all specified medical records, written assessments, therapy documentation, hormone treatment history, and multidisciplinary agreements are included with authorization requests.
- Medical records documentation may be required to assess whether the member meets clinical criteria for coverage and lack of documentation may result in denial.
- Include all procedure‑specific documentation (e.g., presurgical voice therapy, hormone therapy duration, real‑life experience) to reduce denial risk.
Avoid requests for cosmetic or out‑of‑country services that are excluded
Do not submit claims for services that do not meet the policy’s coverage indications (including cosmetic procedures) or for services received outside the United States; coverage does not apply if the member does not meet the Coverage Rationale indications.
- Cosmetic procedures listed in the policy are considered not medically necessary when performed as part of gender-affirming surgical treatment.
- Treatment received outside of the United States is an example of a service that is not covered.
Risk of denial for genital surgery performed before age or without multidisciplinary agreement
Ensure genital surgery is not performed before the recommended age or without documented agreement from a mental health practitioner and endocrine clinician; operating outside these age and multidisciplinary criteria may risk nonconcordance with guidelines and potential denial.
- Endocrine Society suggests delaying genital surgery until at least 18 years or legal age of majority.
- Document multidisciplinary agreement and clinician clearance in the medical record for authorization.
Check and document governing benefit requirements to avoid denial
Confirm and document that coverage determinations follow governing federal, state, or contractual benefit plan requirements; failure to follow these governing requirements may lead to denial.
- Before using this policy, check federal, state, or contractual requirements for benefit plan coverage; these govern in the event of conflict.
- Document verification of applicable governing requirements as part of the authorization submission.
Clinical Background and Evidence Summary
The DSM-5-TR definition of Gender Dysphoria used in the policy requires a marked incongruence between experienced/expressed gender and assigned gender for at least 6 months, accompanied by clinically significant distress or impairment; this definition guides eligibility assessments for gender-affirming treatments.
Surgical gender-affirming interventions described in the policy encompass a range of irreversible procedures intended to align anatomy with an individual’s gender identity (for example mastectomy, vaginoplasty, phalloplasty, orchiectomy, hysterectomy, and related reconstructive procedures), and the policy notes that reversal procedures may be considered in rare cases if medical necessity criteria for reversal are met.
The policy defines genital gender-affirming surgery (GAS) to include procedures such as phalloplasty, metoidioplasty, vaginoplasty, vaginectomy, penectomy, orchiectomy, scrotoplasty, and associated reconstructive operations (for example, urethroplasty and testicular prosthesis placement).
These procedures are discussed in the clinical evidence section with reported outcomes and complication profiles—for example, systematic reviews summarized for phalloplasty and transfemale vaginoplasty—informing the policy’s coverage and documentation expectations.
The policy cites major clinical practice sources informing recommendations, including the American College of Obstetricians and Gynecologists (ACOG) and the Endocrine Society practice guidelines (Hembree et al., 2017); it also references WPATH standards where applicable and includes an informational note about the FDA regulatory status of surgical procedures and devices.
These guideline sources are used to frame timing, age, multidisciplinary assessment, and hormone therapy prerequisites that the policy uses to determine medical necessity and authorization requirements.
The policy’s clinical evidence summaries reference multiple systematic reviews and cohort studies across non-genital and genital procedures: for example, reviews of sex reassignment surgery outcomes (Almazan et al., Wernick et al.), breast surgery outcomes and complications (Oles et al., Sijben et al.), voice feminization interventions (Lanham et al.), and genital surgery outcome meta-analyses (Wang et al., Bustos et al., Dreher et al., Sutcliffe et al.).
These evidence sources report varied metrics including complication rates, patient-reported satisfaction, functional outcomes, and methodological limitations—findings the policy uses to support conservative, guideline-aligned prerequisites and documentation requirements for coverage decisions.
Key Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.